🇺🇸 FDA
Patent

US 10570128

Agonists of the apelin receptor and methods of use thereof

granted A61KA61K31/4196A61K31/422

Quick answer

US patent 10570128 (Agonists of the apelin receptor and methods of use thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4196, A61K31/422, A61K31/427, A61K31/4709